Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Safety evaluation of a recombinant plasmin derivative lacking kringles 2-5 and rt-PA in a rat model of transient ischemic stroke.

Crumrine RC, Marder VJ, Taylor GM, LaManna JC, Tsipis CP, Novokhatny V, Scuderi P, Petteway SR Jr, Arora V.

Exp Transl Stroke Med. 2012 May 16;4(1):10. doi: 10.1186/2040-7378-4-10.

2.

Intra-arterial administration of recombinant tissue-type plasminogen activator (rt-PA) causes more intracranial bleeding than does intravenous rt-PA in a transient rat middle cerebral artery occlusion model.

Crumrine RC, Marder VJ, Taylor GM, Lamanna JC, Tsipis CP, Scuderi P, Petteway SR Jr, Arora V.

Exp Transl Stroke Med. 2011 Sep 20;3(1):10. doi: 10.1186/2040-7378-3-10.

3.

Effects of the cFMS kinase inhibitor 5-(3-methoxy-4-((4-methoxybenzyl)oxy)benzyl)pyrimidine-2,4-diamine (GW2580) in normal and arthritic rats.

Conway JG, Pink H, Bergquist ML, Han B, Depee S, Tadepalli S, Lin P, Crumrine RC, Binz J, Clark RL, Selph JL, Stimpson SA, Hutchins JT, Chamberlain SD, Brodie TA.

J Pharmacol Exp Ther. 2008 Jul;326(1):41-50. doi: 10.1124/jpet.107.129429. Epub 2008 Apr 23.

PMID:
18434589
4.

Inhibition of tumor necrosis factor-alpha (TNF-alpha) production and arthritis in the rat by GW3333, a dual inhibitor of TNF-alpha-converting enzyme and matrix metalloproteinases.

Conway JG, Andrews RC, Beaudet B, Bickett DM, Boncek V, Brodie TA, Clark RL, Crumrine RC, Leenitzer MA, McDougald DL, Han B, Hedeen K, Lin P, Milla M, Moss M, Pink H, Rabinowitz MH, Tippin T, Scates PW, Selph J, Stimpson SA, Warner J, Becherer JD.

J Pharmacol Exp Ther. 2001 Sep;298(3):900-8.

PMID:
11504783
5.

Lamotrigine attenuates cortical glutamate release during global cerebral ischemia in pigs on cardiopulmonary bypass.

Conroy BP, Black D, Lin CY, Jenkins LW, Crumrine RC, DeWitt DS, Johnston WE.

Anesthesiology. 1999 Mar;90(3):844-54.

PMID:
10078687
6.

Lamotrigine protects hippocampal CA1 neurons from ischemic damage after cardiac arrest.

Crumrine RC, Bergstrand K, Cooper AT, Faison WL, Cooper BR.

Stroke. 1997 Nov;28(11):2230-6; discussion 2237.

PMID:
9368570
7.

Attenuation of p53 expression protects against focal ischemic damage in transgenic mice.

Crumrine RC, Thomas AL, Morgan PF.

J Cereb Blood Flow Metab. 1994 Nov;14(6):887-91.

PMID:
7929653
8.

Evaluation of experimental early acute cerebral ischemia before the development of edema: use of dynamic, contrast-enhanced and diffusion-weighted MR scanning.

Finelli DA, Hopkins AL, Selman WR, Crumrine RC, Bhatti SU, Lust WD.

Magn Reson Med. 1992 Sep;27(1):189-97. Erratum in: Magn Reson Med 1992 Dec;28(2):339.

PMID:
1435205
9.

Protein kinase C activity in permanent focal cerebral ischemia.

Crumrine RC, Selman WR, LaManna JC, Lust WD.

Mol Chem Neuropathol. 1992 Feb-Apr;16(1-2):85-93.

PMID:
1520407
11.

Rapid metabolic failure in spontaneously hypertensive rats after middle cerebral artery ligation.

Selman WR, Crumrine RC, Rosenstein CC, Jenkins C, LaManna JC, Ratcheson RA, Lust WD.

Metab Brain Dis. 1991 Jun;6(2):57-64.

PMID:
1749364
12.
13.

Decreased protein kinase C activity during cerebral ischemia and after reperfusion in the adult rat.

Crumrine RC, Dubyak G, LaManna JC.

J Neurochem. 1990 Dec;55(6):2001-7.

PMID:
2230806
14.

Protein kinase C activity in rat brain cortex.

Crumrine RC, LaManna JC.

J Neurochem. 1990 Sep;55(3):826-31.

PMID:
2384756
15.

The evolution of focal ischemic damage: a metabolic analysis.

Selman WR, Ricci AJ, Crumrine RC, LaManna JC, Ratcheson RA, Lust WD.

Metab Brain Dis. 1990 Mar;5(1):33-44.

PMID:
2336048
16.

Impairment of metabolic recovery with increasing periods of middle cerebral artery occlusion in rats.

Selman WR, Crumrine RC, Ricci AJ, LaManna JC, Ratcheson RA, Lust WD.

Stroke. 1990 Mar;21(3):467-71.

PMID:
2309272
17.

Use of transthoracic bioimpedance to determine cardiac output in pediatric patients.

Introna RP, Pruett JK, Crumrine RC, Cuadrado AR.

Crit Care Med. 1988 Nov;16(11):1101-5.

PMID:
3168502
18.
19.

Decreased blood volume with hypoperfusion during recovery from total cerebral ischaemia in dogs.

LaManna JC, Romeo SA, Crumrine RC, McCracken KA.

Neurol Res. 1985 Sep;7(3):161-5.

PMID:
2866461
20.

Naloxone therapy during focal cerebral ischemia evaluation in a primate model.

Zabramski JM, Spetzler RF, Selman WR, Roessmann UR, Hershey LA, Crumrine RC, Macko R.

Stroke. 1984 Jul-Aug;15(4):621-7.

PMID:
6464054
21.

Barbiturate-induced coma therapy for focal cerebral ischemia. Effect after temporary and permanent MCA occlusion.

Selman WR, Spetzler RF, Roessmann UR, Rosenblatt JI, Crumrine RC.

J Neurosurg. 1981 Aug;55(2):220-6.

PMID:
7252545
22.

Management of prolonged therapeutic barbiturate coma.

Selman WR, Spetzler RF, Anton AH, Crumrine RC.

Surg Neurol. 1981 Jan;15(1):9-10.

PMID:
7256531
23.

Chronic reversible cerebral ischemia: evaluation of a new baboon model.

Spetzler RF, Selman WR, Weinstein P, Townsend J, Mehdorn M, Telles D, Crumrine RC, Macko R.

Neurosurgery. 1980 Sep;7(3):257-61.

PMID:
7207743

Supplemental Content

Loading ...
Support Center